159 related articles for article (PubMed ID: 34858826)
1. Large Multicohort Study Reveals a Prostate Cancer Susceptibility Allele at 5p15 Regulating
Dong X; Zhang Q; Hao J; Xie Q; Xu B; Zhang P; Lu H; Huang Q; Yang T; Wei GH; Na R; Gao P
Front Oncol; 2021; 11():754206. PubMed ID: 34858826
[TBL] [Abstract][Full Text] [Related]
2. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
Ko E; Seo HW; Jung ES; Kim BH; Jung G
Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
[TBL] [Abstract][Full Text] [Related]
3. Functional dissection of breast cancer risk-associated
Helbig S; Wockner L; Bouendeu A; Hille-Betz U; McCue K; French JD; Edwards SL; Pickett HA; Reddel RR; Chenevix-Trench G; Dörk T; Beesley J
Oncotarget; 2017 Sep; 8(40):67203-67217. PubMed ID: 28978027
[TBL] [Abstract][Full Text] [Related]
4. Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.
Vinothkumar V; Arun K; Arunkumar G; Revathidevi S; Ramani R; Bhaskar LVKS; Murugan AK; Munirajan AK
Mol Clin Oncol; 2020 May; 12(5):485-494. PubMed ID: 32257207
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutations in soft tissue sarcomas.
Campanella NC; Penna V; Abrahão-Machado LF; Cruvinel-Carloni A; Ribeiro G; Soares P; Scapulatempo-Neto C; Reis RM
Int J Biol Markers; 2016 Feb; 31(1):e62-7. PubMed ID: 26391479
[TBL] [Abstract][Full Text] [Related]
6. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
[TBL] [Abstract][Full Text] [Related]
7. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W
Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309
[TBL] [Abstract][Full Text] [Related]
8. Targeting oncogenic TERT promoter variants by allele-specific epigenome editing.
Kouroukli AG; Rajaram N; Bashtrykov P; Kretzmer H; Siebert R; Jeltsch A; Bens S
Clin Epigenetics; 2023 Nov; 15(1):183. PubMed ID: 37993930
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells.
Hirokawa T; Arimasu Y; Chiba T; Nakazato Y; Fujiwara M; Kamma H
Pathobiology; 2020; 87(6):338-344. PubMed ID: 33227798
[TBL] [Abstract][Full Text] [Related]
11. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
[TBL] [Abstract][Full Text] [Related]
12.
Giunco S; Boscolo-Rizzo P; Rampazzo E; Tirelli G; Alessandrini L; Di Carlo R; Rossi M; Nicolai P; Menegaldo A; Carraro V; Tofanelli M; Bandolin L; Spinato G; Emanuelli E; Mantovani M; Stellin M; Bussani R; Dei Tos AP; Guido M; Morello M; Fussey J; Esposito G; Polesel J; De Rossi A
Front Oncol; 2021; 11():782658. PubMed ID: 34858860
[TBL] [Abstract][Full Text] [Related]
13. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
14. TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.
Shadrina AS; Boyarskikh UA; Oskina NA; Sinkina TV; Lazarev AF; Petrova VD; Filipenko ML
Tumour Biol; 2015 Feb; 36(2):841-7. PubMed ID: 25296732
[TBL] [Abstract][Full Text] [Related]
15. Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis.
Shen N; Lu Y; Wang X; Peng J; Zhu Y; Cheng L
Oncotarget; 2017 Aug; 8(31):50864-50872. PubMed ID: 28881610
[TBL] [Abstract][Full Text] [Related]
16. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
17. Possible association of the TERT promoter polymorphisms rs2735940, rs7712562 and rs2853669 with diabetes mellitus in obese elderly Polish population: results from the national PolSenior study.
Gutmajster E; Chudek J; Augusciak-Duma A; Szwed M; Szybalska A; Mossakowska M; Puzianowska-Kuznicka M; Wiecek A; Sieron AL
J Appl Genet; 2018 Aug; 59(3):291-299. PubMed ID: 29938393
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma.
Hirokawa T; Arimasu Y; Chiba T; Fujiwara M; Kamma H
Pathol Int; 2020 Apr; 70(4):217-223. PubMed ID: 31943527
[TBL] [Abstract][Full Text] [Related]
19. The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancer.
Valdez CD; Kunju L; Daignault S; Wojno KJ; Day ML
Prostate; 2013 Dec; 73(16):1776-85. PubMed ID: 24038143
[TBL] [Abstract][Full Text] [Related]
20. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
